Results 131 to 140 of about 21,523 (223)

5-Aminosalicylic Acid Chemoprevention in Inflammatory Bowel Diseases: Is It Necessary in the Age of Biologics and Small Molecules? [PDF]

Inflamm Intest Dis, 2022
Herfarth H, Vavricka SR.
europepmc   +1 more source

Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis [PDF]

, 2003
Berlanga-Acosta, J, Nightingale, JMD, Playford, RJ, Sinha, A, West, KP   +4 more
core   +1 more source

Optimizing 5-Aminosalicylic Acid Maintenance Treatment in Ulcerative Colitis from the Patient and Physician Perspective: A Cross-sectional Multicenter Study. [PDF]

Crohns Colitis 360
Amano T, Yoshihara T, Nishida T, Sakakibara Y, Yamada T, Hiyama S, Murayama Y, Osugi N, Ogiyama H, Nagaike K, Arimoto Y, Kawai S, Yamaguchi T, Kitamura S, Ogawa H, Egawa S, Ishii S, Kizu T, Komori M, Tsujii Y, Asakura A, Tashiro T, Tani M, Otake-Kasamoto Y, Uema R, Tsujii Y, Inoue T, Shinzaki S, Iijima H, Hayashi Y, Takehara T.   +30 more
europepmc   +1 more source

The Synergistic Effects of 5-Aminosalicylic Acid and Vorinostat in the Treatment of Ulcerative Colitis. [PDF]

Front Pharmacol, 2021
He L, Wen S, Zhong Z, Weng S, Jiang Q, Mi H, Liu F.   +6 more
europepmc   +1 more source

Pectinase responsive nanoplatform for oral targeted delivery 5-aminosalicylic acid and zinc coordination driven nanozyme in inflammatory bowel disease treatment. [PDF]

Int J Pharm X
Lin Y, Fang S, Chen X, Li X, Zhao X, Wang Y, Lu J, Ji Q, Zheng S, Zou J, Qi C, Gao F.   +11 more
europepmc   +1 more source

5-Aminosalicylic acid ameliorates dextran sulfate sodium-induced colitis in mice by modulating gut microbiota and bile acid metabolism. [PDF]

Cell Mol Life Sci, 2022
Huang L, Zheng J, Sun G, Yang H, Sun X, Yao X, Lin A, Liu H.   +7 more
europepmc   +1 more source

Role of 5-aminosalicylic acid in ulcerative colitis management in 8 Asian territories: a physician survey. [PDF]

Intest Res
Limsrivilai J, Lai AY, Li STH, Abdullah M, Ali RAR, Aniwan S, Bui HH, Chou JW, Hilmi IN, Lim WC, Sollano J, Teo MMH, Wei SC, Leung WK.   +13 more
europepmc   +1 more source

Persistence of newly prescribed 5-aminosalicylic acid in patients with ulcerative colitis: A nationwide comprehensive database study. [PDF]

PLoS One
Noda T, Kuwaki K, Machida M, Okumura Y, Nishioka Y, Myojin T, Imamura T.   +6 more
europepmc   +1 more source

Factors associated with the persistence of oral 5-aminosalicylic acid monotherapy in ulcerative colitis: a nationwide Norwegian cohort study. [PDF]

Ther Adv Gastroenterol, 2021
Fossmark R, Olaisen M, Martinsen TC, Melberg HO.   +3 more
europepmc   +1 more source

Significance of 5-Aminosalicylic Acid Intolerance in the Clinical Management of Ulcerative Colitis.

Digestion, 2023
Mikami Y, Tsunoda J, Suzuki S, Mizushima I, Kiyohara H, Kanai T.   +5 more
europepmc   +1 more source